Mary Beth Fritz - Mar 1, 2024 Form 4 Insider Report for Prestige Consumer Healthcare Inc. (PBH)

Role
SVP Quality & Regulatory
Signature
/s/ Mary Beth Fritz by William P'Pool attorney-in-fact pursuant to power of attorney dated August 7, 2018 on file with the Commission
Stock symbol
PBH
Transactions as of
Mar 1, 2024
Transactions value $
-$5,205
Form type
4
Date filed
3/5/2024, 04:01 PM
Previous filing
Feb 29, 2024
Next filing
May 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PBH Common Stock, par value $0.01 per share Options Exercise $3.55K +62 +0.39% $57.18 16K Mar 1, 2024 Direct
transaction PBH Common Stock, par value $0.01 per share Sale -$4.37K -62 -0.39% $70.43 15.9K Mar 1, 2024 Direct F1
transaction PBH Common Stock, par value $0.01 per share Options Exercise $3.36K +110 +0.69% $30.56 16K Mar 1, 2024 Direct
transaction PBH Common Stock, par value $0.01 per share Sale -$7.75K -110 -0.69% $70.41 15.9K Mar 1, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBH Employee Stock Options (right to buy) Options Exercise $0 -62 -100% $0.00* 0 Mar 1, 2024 Common Stock 62 $57.18 Direct F3
transaction PBH Employee Stock Options (right to buy) Options Exercise $0 -110 -100% $0.00* 0 Mar 1, 2024 Common Stock 110 $30.56 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $70.00 to $70.43.
F2 Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $70.00 to $70.41.
F3 The options vested in three installments on 1,817 shares on May 9, 2017 and 1,818 shares each on May 9, 2018 and May 9, 2019.
F4 The options vested in three installments on 2,540 shares on May 6, 2020 and 2,541shares each on May 6, 2021 and May 6, 2022